Astrana Health Affirms FY2026 Sales Guidance of $3.800B-$4.100B vs $4.001B Est

Benzinga Newsdesk www.benzinga.com Negative 78.7%

Neg 78.7% Neu 0% Pos 0%

Astrana Health (NASDAQ:ASTH) affirms FY2026 sales outlook from $3.800 billion-$4.100 billion to $3.800 billion-$4.100 billion vs $4.001 billion estimate.